TissueForm supplies natural replacement biomaterials to the next generation of implantable medical devices to positively impact patients suffering from tissue loss due to disease, damage, or aging.
Using bio-inspired design principles, and advanced tools of biotechnology, TissueForm has developed a platform technology for the biomimicry of body tissues to repair areas of significant tissue loss or injury. The catalogue of products in development include a dermal filler material (NatruDerme) and and an effective articular cartilage repair material (NatruLage). The platform material technology is characterized by a unique combination of acellular particles crosslinked to natural biomolecules that provides tissue-specific properties and performance, while also allowing for easy forming and integration upon delivery to the patient, and low-cost fabrication. The acellular materials maintain tissue-specific structure and proteins to promote rapid healing and durable repair.
Company Details
- Employees
- 2
- Address
- Boulder, Colorado 80305, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.tissueforminc.com
- HQ
- Boulder, Colorado
Tissueform, Inc. Questions
Tissueform, Inc.'s website is http://www.tissueforminc.com
Tissueform, Inc.'s LinkedIn profile is https://www.linkedin.com/company/tissueform
Tissueform, Inc. has
2 employees.
View email and phone details for 2
employees at Tissueform, Inc..
Tissueform, Inc.'s industry is
Biotechnology Research
Tissueform, Inc.'s top competitors are
Umoja Biopharma,
Biodesix, Inc.,
Aoa Dx,
Aspero Medical,
Gelsana,
Darwin Biosciences,
Elysium Therapeutics, Inc.,
Medtronic,
Enveda,
Ambrosia Biosciences Inc..
Tissueform, Inc.'s categories are Biotechnology Research
